Children living with HIV have to take multiple different antiretroviral pills or syrups twice a day, while most adults in South Africa have been offered one pill once a day regimens for around a decade. At the recent South African HIV Clinicians Society (SAHCS) conference, various speakers argued that better treatment regimens for kids are needed urgently. Thabo Molelekwa reports.
Studies show that people living with HIV are often at a higher risk for depression and anxiety, including a higher risk of suicide. Tiyese Jeranji spoke to mental health practitioners, activists, and people living with HIV to unpack the link between HIV and mental health.
According to new estimates from the World Health Organization around 61 000 people died of TB in South Africa in 2020, an increase of around 5% over 2019. That works out to over 1 100 TB deaths in the country every week. We urgently need a transparent TB recovery plan and we need both President Cyril Ramaphosa and Health Minister Joe Phaahla to invest real political capital in the implementation of the plan, the authors argue.
“The results are in: artificial intelligence (AI) outperforms humans at reading chest X-rays for signs of tuberculosis,” proclaimed a recent newsletter of the Stop TB Partnership. Tiyese Jeranji spoke to a variety of experts about the landmark study behind this proclamation and asked what AI-aided X-ray interpretation may mean for countries like South Africa with high TB burdens.
Although it is necessary for the criminal justice system to prohibit and punish conduct that is harmful to the public interest, criminalising exposure to or transmission of HIV goes against important public health principles, writes Sibusisiwe Ndlela.
Findings of a clinic monitoring report released last week, again highlighted how delivery of health services in the Eastern Cape are hamstrung by staff and medicine shortages. Luvuyo Mehlwana unpacks the data and the provincial health department’s plans to address the challenges identified in the report.
Already very long waiting times for gender-affirming surgery in South Africa’s public sector have gotten even longer due to the COVID-19 pandemic. Tiyese Jeranji investigates the challenges transgender persons in the country face in accessing gender-affirming care.
Findings of two large phase III clinical trials first presented in 2020 showed a new HIV prevention injection to be highly effective. Yet, experts expect that the injection will only reach clinics in late 2022 or early 2023. If the rhetoric about bringing the urgency of COVID-19 to HIV is to mean anything, these timelines should be made shorter.
An antiretroviral injection administered every two months has been shown to be highly effective in preventing people from getting HIV in two large trials. Catherine Tomlinson asks what needs to happen before these injections become available to people in South Africa.
One of the most vibrant areas of HIV research these days is the search for new, more convenient ways to use antiretroviral medicines (ARVs) to prevent HIV infection. Elri Voigt rounds up the HIV pre-exposure prophylaxis (PrEP) research presented at the recent International AIDS Society Conference, including a biodegradable antiretroviral implant.
For Dr Caroline Pule, a biomedical scientist working in tuberculosis (TB) research, her passion for finding answers that can help ease the suffering caused by diseases such as TB started with a promise she wrote in her diary when she was 13 years old. Tiyese Jeranji spoke to Pule about following her dream of saving lives and teaching young girls to believe in possibilities.
Professor Koleka Mlisana is co-chair of South Africa’s COVID-19 Ministerial Advisory Committee. Ufrieda Ho interviewed her about her love of science, her career, and her role in the fight against COVID-19.
